Small interference RNA targeting vascular endothelial growth factor gene effectively attenuates retinal

Yi-chun Kong1, Bei Sun, Kan-xing Zhao

  • 1Tianjin Eye Hospital; Tianjin Key Lab of Ophthalmology and Visual Science; Tianjin Eye Institute; Clinical College of Ophthalmology, Tianjin Medical University, Tianjin 300020, China (Email: kongyc1942@hotmail.com).

Abstract

Insights

Small interference RNA (siRNA) targeting vascular endothelial growth factor (VEGF) effectively reduced VEGF expression in oxygen-induced retinopathy (OIR) models. This therapeutic strategy attenuated retinal neovascularization by modulating the VEGF to PEDF ratio.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genetics

Background:

  • Retinal neovascularization mechanisms remain incompletely understood.
  • Vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) are key regulators of angiogenesis.
  • Oxygen-induced retinopathy (OIR) serves as a model for studying retinal neovascularization.

Purpose of the Study:

  • To investigate the efficacy of VEGF-targeting small interference RNA (siRNA) in attenuating OIR.
  • To evaluate the impact of VEGF-siRNA on the VEGF to PEDF ratio in OIR models.

Main Methods:

  • In vitro: EOMA cells were transfected with VEGF-siRNA; VEGF mRNA and protein levels were assessed via real-time PCR and Western blotting.
  • In vivo: OIR mice received intra-vitreal injections of VEGF-siRNA; retinal VEGF and PEDF protein levels were measured by Western blotting.
  • Retinal neovascularization was visualized and quantified using fluorescein angiography.

Main Results:

  • VEGF-siRNA significantly reduced VEGF mRNA and protein expression in vitro.
  • In vivo, VEGF-siRNA treatment led to decreased VEGF levels and an altered VEGF/PEDF ratio.
  • Significant attenuation of retinal neovascularization, including reduced neovascular tufts and improved vascular integrity, was observed.

Conclusions:

  • VEGF plays a critical role in oxygen-induced retinopathy.
  • VEGF-siRNA effectively downregulates VEGF expression in vivo, impacting the VEGF/PEDF ratio.
  • Targeting VEGF with RNA interference presents a potential therapeutic strategy for retinal neovascularization.